Harrison & Co Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Harrison & Co Wealth Management's PFE Position: Q4 2022 in Review
Harrison & Co Wealth Management increased its Pfizer (PFE) stake by 0.77% in Q4 2022, buying an estimated $7.96K and bringing the position to 21,755 shares worth $1.11M. The position accounts for 1.08% of the portfolio, ranked #24.
Harrison & Co Wealth Management first reported a position in PFE in Q4 2021 and has held it in 5 quarters since. The position peaked at $1.46M in Q4 2021. 3,268 funds tracked by Wall St. Rank hold PFE as of Q4 2022.
- Harrison & Co Wealth Management held 21,755 shares of Pfizer worth $1.11M as of Q4 2022.
- Harrison & Co Wealth Management bought 166 Pfizer shares in Q4 2022, an estimated $7.96K.
- Pfizer made up 1.08% of Harrison & Co Wealth Management's portfolio in Q4 2022, its #24 holding.
- Harrison & Co Wealth Management first reported a position in Pfizer in Q4 2021 and has held it in 5 quarters since.
- Harrison & Co Wealth Management's Pfizer position peaked at $1.46M in Q4 2021.
- 3,268 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.
Based on Harrison & Co Wealth Management's 13F filing for Q4 2022, filed 17 Jan 2023.